Free Trial
NASDAQ:GRTX

Galera Therapeutics (GRTX) Stock Price, News & Analysis

Galera Therapeutics logo
$0.03 +0.00 (+3.27%)
As of 03:34 PM Eastern

About Galera Therapeutics Stock (NASDAQ:GRTX)

Key Stats

Today's Range
$0.03
$0.03
50-Day Range
$0.02
$0.03
52-Week Range
$0.02
$0.14
Volume
46,949 shs
Average Volume
93,435 shs
Market Capitalization
$2.14 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Galera Therapeutics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
6th Percentile Overall Score

GRTX MarketRank™: 

Galera Therapeutics scored higher than 6% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Galera Therapeutics.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Galera Therapeutics is -0.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Galera Therapeutics is -0.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Galera Therapeutics' valuation and earnings.
  • Percentage of Shares Shorted

    0.02% of the float of Galera Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Galera Therapeutics has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

  • Dividend Yield

    Galera Therapeutics does not currently pay a dividend.

  • Dividend Growth

    Galera Therapeutics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.02% of the float of Galera Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Galera Therapeutics has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

  • Search Interest

    1 people have searched for GRTX on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Galera Therapeutics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    12.90% of the stock of Galera Therapeutics is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    50.77% of the stock of Galera Therapeutics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Galera Therapeutics' insider trading history.
Receive GRTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Galera Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

GRTX Stock News Headlines

GRTX Galera Therapeutics, Inc. - Seeking Alpha
Galera Therapeutics extends agreement deadline
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
Newron Pharmaceuticals S.p.A. (NP5.DE)
See More Headlines

GRTX Stock Analysis - Frequently Asked Questions

Galera Therapeutics' stock was trading at $0.0458 at the start of the year. Since then, GRTX shares have decreased by 38.0% and is now trading at $0.0284.

Galera Therapeutics, Inc. (NASDAQ:GRTX) released its quarterly earnings results on Wednesday, November, 10th. The company reported ($0.86) earnings per share for the quarter, missing the consensus estimate of ($0.71) by $0.15.

Galera Therapeutics (GRTX) raised $75 million in an initial public offering (IPO) on Thursday, November 7th 2019. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch, Citigroup and Credit Suisse served as the underwriters for the IPO and BTIG was co-manager.

Shares of GRTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Galera Therapeutics investors own include Energy Transfer (ET), Plug Power (PLUG), NGL Energy Partners (NGL), Universal Display (OLED), Nextera Energy Partners (NEP), Verastem (VSTM) and Alerian MLP ETF (AMLP).

Company Calendar

Last Earnings
11/10/2021
Today
7/09/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:GRTX
CIK
1563577
Fax
N/A
Employees
30
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$59.08 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
($2.41) per share
Price / Book
-0.01

Miscellaneous

Free Float
47,375,000
Market Cap
$2.11 million
Optionable
Optionable
Beta
1.89
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:GRTX) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners